{
  "retracted": false,
  "timestamp": 1459296000000,
  "updates": [
    {
      "timestamp": 1585083365584,
      "identifier": {
        "doi": "10.1007/s10456-016-9507-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10456-016-9499-4"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization"
}
